TaVNS for Delirium
RecruitingNCT07258082Phase: NAStarted 2025-09-26
Summary
The goal of this clinical trial is to test whether a non-invasive device called transauricular vagus nerve stimulation (taVNS) is safe, practical, and potentially helpful for patients in the hospital
Eligibility
Sex
ALL
Min Age
22 Years
Max Age
None
Locations
Stony Brook University HospitalStony Brook, New York, United States
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07258082